Holen Sie sich die Stockscreener-App
0.3706
1.89%
-0.0108
Schlusskurs vom Vortag:
$0.3814
Offen:
$0.3742
24-Stunden-Volumen:
72,675
Relative Volume:
0.04
Marktkapitalisierung:
$8.08M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.07M
KGV:
-0.0641
EPS:
-5.78
Netto-Cashflow:
$-7.34M
1W Leistung:
-6.80%
1M Leistung:
+6.91%
6M Leistung:
-47.30%
1J Leistung:
-60.61%
1-Tages-Spanne:
$0.37
$0.38
1-Wochen-Bereich:
$0.364
$0.43
52-Wochen-Spanne:
$0.22
$1.30
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Firmenname
Adial Pharmaceuticals Inc
Sektor
Branche
Telefon
434-422-9800
Adresse
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Vergleichen Sie ADIL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
0.37 | 8.33M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.74 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.18 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.12 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
329.04 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2018-10-30 | Eingeleitet | Maxim Group | Buy |
| 2018-10-11 | Eingeleitet | Dawson James | Buy |
Adial Pharmaceuticals Inc Aktie (ADIL) Neueste Nachrichten
Using R and stats models for Adial Pharmaceuticals Inc. forecasting2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com
Relative strength of Adial Pharmaceuticals Inc. in sector analysisJuly 2025 Sector Moves & AI Enhanced Trading Alerts - newser.com
Should I hold or sell Adial Pharmaceuticals Inc. stock in 2025July 2025 Pullbacks & Free Safe Capital Growth Stock Tips - newser.com
Adial completes key validation for alcohol disorder treatment test By Investing.com - Investing.com Nigeria
Adial completes key validation for alcohol disorder treatment test - Investing.com
Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution - GlobeNewswire
100% SNP concordance: Adial and Genomind validate cheek‑swab test for AD04; AG+ biomarker ~14% - Stock Titan
Top chart patterns to watch in Adial Pharmaceuticals Inc.Gap Up & Smart Investment Allocation Insights - newser.com
Will Adial Pharmaceuticals Inc. benefit from macro trendsWeekly Earnings Recap & Real-Time Volume Trigger Notifications - newser.com
Nxera Pharma (OTCMKTS:SOLTF) and Adial Pharmaceuticals (NASDAQ:ADIL) Head to Head Survey - Defense World
Why Adial Pharmaceuticals Inc. stock is a must watch in 2025Weekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
What recovery options are there for Adial Pharmaceuticals Inc.July 2025 Gainers & Comprehensive Market Scan Reports - newser.com
Should you hold or exit Adial Pharmaceuticals Inc. nowJuly 2025 Update & AI Driven Stock Reports - newser.com
How moving averages guide Adial Pharmaceuticals Inc. tradingMarket Weekly Review & Daily Volume Surge Signals - newser.com
Maxim Group Upgrades Adial Pharmaceuticals (ADIL) - Nasdaq
This Semtech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
What drives Adial Pharmaceuticals Inc stock priceLong-Term Growth Stocks & High Profit Trading Signals - earlytimes.in
Adial Pharmaceuticals (ADIL) Upgraded by Maxim Group | ADIL Stoc - GuruFocus
Is Adial Pharmaceuticals Inc affected by consumer sentimentWeekly Earnings Recap & Daily Growth Stock Tips - خودرو بانک
Dividend Watch: Is The First of Long Island Corporation showing insider buyingEntry Point & Real-Time Buy Zone Alerts - khodrobank.com
Is Adial Pharmaceuticals Inc. stock bottoming outWatch List & Fast Moving Stock Trade Plans - newser.com
Why Adial Pharmaceuticals Inc. is moving todayMarket Performance Report & Free Real-Time Volume Trigger Notifications - newser.com
Layoff Watch: Is Adial Pharmaceuticals Inc affected by consumer sentimentEarnings Beat & Growth Focused Stock Pick Reports - khodrobank.com
New Highs: What are Adial Pharmaceuticals Incs technical support levelsWeekly Risk Summary & Fast Entry and Exit Trade Plans - khodrobank.com
RSI Check: Can Adial Pharmaceuticals Inc weather a recessionJuly 2025 Macro Moves & Fast Gain Swing Alerts - خودرو بانک
Insider Buy: Will Canadian Solar Inc benefit from green energy policiesJuly 2025 Spike Watch & Low Volatility Stock Suggestions - khodrobank.com
What MACD and RSI say about Adial Pharmaceuticals Inc.Quarterly Risk Review & Weekly Return Optimization Alerts - newser.com
Profit Recap: Why is UMBF stock going up2025 Top Gainers & Safe Investment Capital Preservation Plans - خودرو بانک
Stock Market Recap: How correlated is Nixxy Inc to the S P500Weekly Trade Summary & Growth Focused Stock Pick Reports - khodrobank.com
Movement Recap: Will Barfresh Food Group Inc outperform the market in YEAR2025 Analyst Calls & Weekly Setup with High ROI Potential - khodrobank.com
Aug Volume: Is The Home Depot Inc.’s growth already priced inWeekly Trading Summary & AI Driven Stock Movement Reports - khodrobank.com
Rate Hike: Whats the fair value of Adial Pharmaceuticals Inc stockJuly 2025 Earnings & Verified Chart Pattern Signals - خودرو بانک
Reversal indicators forming on Adial Pharmaceuticals Inc. stockJuly 2025 Drop Watch & Capital Efficient Trade Techniques - newser.com
Will a bounce in Adial Pharmaceuticals Inc. offer an exitIPO Watch & Long-Term Capital Growth Strategies - newser.com
Quarterly Recap: Is OPEN stock a hidden gemMarket Activity Recap & Weekly Breakout Watchlists - خودرو بانک
Market Outlook: Can RITR outperform under higher oil pricesJuly 2025 Action & Fast Gaining Stock Reports - khodrobank.com
Certain Stock Options of Adial Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 17-SEP-2025. - MarketScreener
Certain Common Stock of Adial Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 17-SEP-2025. - MarketScreener
Finanzdaten der Adial Pharmaceuticals Inc-Aktie (ADIL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.21%
2.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):